Clinical Trials

Simple medical device improves care after kidney transplantation

- Clinical trial shows patients prescribed the geko™ device experienced shortened hospital stays by more than one day after a kidney transplant - The device reduced surgical...

First Patient Treated in Landmark U.S. Randomized Clinical Trial of NeuraLace’s Chronic Pain Treatment

Study to Evaluate the Efficacy and Economic Benefit of Axon Therapy® Designed to Relieve Pain and Improve Quality of Life Compared with Conventional Medical...

Bivacor lands $22M to begin human trials of its magnetic artificial heart

On a scale of cardiac density that begins with Blondie’s heart of glass and ends with the Rolling Stones’ heart of stone, Houston-based startup Bivacor’s...

ReCor Medical has positive renal denervation study news

ReCor Medical‘s renal denervation significantly reduced blood pressure among people with drug-resistant hypertension, according to a new study reported at the American College of...

Brave new world: trialling VR to ease pain and stress

Virtual reality has shown the potential to help patients deal with pain and anxiety during difficult procedures and clinical trials. Clinical Trials Arena speaks...

FDA Grants RenovaCare Full IDE Approval for Safety and Feasibility Clinical Trial

RenovaCare, Inc., announced that its Investigational Device Exemption (IDE) application has been granted full approval by the U.S. Food and Drug Administration (FDA). This...

NanoVibronix Announces Start of Real World Patient Study of UroShield

NanoVibronix, Inc., a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that...

Innocoll Biotherapeutics initiates Phase 3 trials for collagen drug-device

Innocoll Biotherapeutics announced that it initiated two Phase 3 trials to support a label expansion for its collagen drug-device implant. Athlone, Ireland-based Innocoll’s trials are seeking...

Novocure Announces Update on Phase 3 Pivotal LUNAR Trial

International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4 non-small cell...
1...515253...58Page 52 of 58

Latest articles